Sarepta Therapeutics, Inc. financial data

Symbol
SRPT on Nasdaq
Location
215 First Street, Suite 415, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 342 % -12.8%
Quick Ratio 118 % +79.5%
Debt-to-equity 173 % -24.1%
Return On Equity -20.3 % -272%
Return On Assets -7.44 % -306%
Operating Margin -5.24 % -206%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +9.7%
Common Stock, Shares, Outstanding 105M shares +9.71%
Common Stock, Value, Issued 11K USD +10%
Weighted Average Number of Shares Outstanding, Basic 100M shares +5.08%
Weighted Average Number of Shares Outstanding, Diluted 100M shares -0.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.41B USD +47.1%
Revenue from Contract with Customer, Excluding Assessed Tax 2.13B USD +40.8%
Costs and Expenses 2.54B USD +62.9%
Operating Income (Loss) -127M USD -256%
Nonoperating Income (Expense) -126M USD -360%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -252M USD -295%
Income Tax Expense (Benefit) 19.3M USD +156%
Net Income (Loss) Attributable to Parent -272M USD -323%
Earnings Per Share, Basic -2 USD/shares -271%
Earnings Per Share, Diluted -2 USD/shares -288%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 613M USD +210%
Cash, Cash Equivalents, and Short-term Investments 1.69B USD -15.8%
Accounts Receivable, after Allowance for Credit Loss, Current 396M USD -8.93%
Inventory, Net 1.08B USD +90.3%
Other Assets, Current 192M USD +16.2%
Assets, Current 2.72B USD +1.38%
Property, Plant and Equipment, Net 359M USD +17.4%
Operating Lease, Right-of-Use Asset 139M USD -1.23%
Other Assets, Noncurrent 73.4M USD -12.2%
Assets 3.49B USD -2.96%
Accounts Payable, Current 94M USD -20.8%
Employee-related Liabilities, Current 31M USD -45.8%
Accrued Liabilities, Current 296M USD -14.2%
Contract with Customer, Liability, Current 485M USD +282%
Liabilities, Current 921M USD +31.7%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 215M USD +26.5%
Other Liabilities, Noncurrent 1.4M USD +40.4%
Liabilities 2.17B USD -8.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax 220K USD -90.2%
Retained Earnings (Accumulated Deficit) -4.64B USD -6.21%
Stockholders' Equity Attributable to Parent 1.32B USD +8.11%
Liabilities and Equity 3.49B USD -2.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -583M USD -141%
Net Cash Provided by (Used in) Financing Activities 12.5M USD -43.7%
Net Cash Provided by (Used in) Investing Activities -291M USD -233%
Common Stock, Shares Authorized 198M shares 0%
Common Stock, Shares, Issued 105M shares +10.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -862M USD -75527%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 626M USD +193%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.19M USD 0%
Deferred Tax Assets, Valuation Allowance 888M USD +0.53%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 923M USD +1.21%
Operating Lease, Liability 206M USD +29.6%
Payments to Acquire Property, Plant, and Equipment 43.7M USD +34.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -274M USD -319%
Lessee, Operating Lease, Liability, to be Paid 382M USD -4.11%
Property, Plant and Equipment, Gross 574M USD +37.4%
Operating Lease, Liability, Current 13.3M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 31.5M USD -8.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 31.8M USD -5.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 177M USD -26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 31.6M USD +12.7%
Deferred Tax Assets, Operating Loss Carryforwards 67.6M USD -56.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3.33M shares 0%
Unrecognized Tax Benefits 66.5M USD +2.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 32.3M USD +15.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 11.1M USD
Current Federal Tax Expense (Benefit) 4.18M USD
Amortization of Intangible Assets 2.55M USD -0.82%
Depreciation, Depletion and Amortization 9.98M USD +14.1%
Share-based Payment Arrangement, Expense 14.9M USD -65.7%
Interest Expense -15.7M USD +52.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%